NASDAQ:CYTK • US23282W6057
Past quarterly earnings results for CYTOKINETICS INC (CYTK), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.50 | -1.49 | -0.97% | -19.05% | 17.755M | 7.049M | 151.88% | 4.89% |
| Q3 2025 | -2.55 | -1.61 | -58.24% | -87.50% | 1.936M | 3.627M | -46.62% | 318.14% |
| Q2 2025 | -1.12 | -1.40 | 20.28% | 14.50% | 66.769M | 2.431M | 2,646.57% | 26,714.86% |
| Q1 2025 | -1.39 | -1.41 | 1.37% | -4.51% | 1.579M | 1.227M | 28.69% | 89.10% |
| Q4 2024 | -1.26 | -1.22 | -3.56% | 8.70% | 16.927M | 1.776M | 853.10% | 912.38% |
| Q3 2024 | -1.36 | -1.27 | -6.82% | -0.74% | 463K | 1.219M | -62.02% | 22.49% |
| Q2 2024 | -1.31 | -1.08 | -21.59% | 2.24% | 249K | 940.012K | -73.51% | -71.28% |
| Q1 2024 | -1.33 | -1.16 | -14.19% | 3.62% | 835K | 917.612K | -9.00% | -81.90% |
| Q4 2023 | -1.38 | -0.99 | -39.39% | 4.83% | 1.672M | 10.985M | -84.78% | -14.69% |
| Q3 2023 | -1.35 | -0.76 | -78.29% | 11.18% | 378K | 20.649M | -98.17% | -85.00% |
| Q2 2023 | -1.34 | -1.17 | -14.64% | -482.61% | 867K | 5.92M | -85.35% | -99.03% |
| Q1 2023 | -1.38 | -1.22 | -12.82% | -35.29% | 4.613M | 2.131M | 116.47% | 301.13% |
| Q4 2022 | -1.45 | -1.23 | -17.89% | -302.78% | 1.96M | 7.241M | -72.93% | -96.47% |
| Q3 2022 | -1.52 | -1.19 | -27.35% | -60.00% | 2.52M | 3.017M | -16.47% | -53.68% |
| Q2 2022 | -0.23 | -1.04 | 77.91% | 73.26% | 88.97M | 3.704M | 2,302.00% | 3,032.75% |
| Q1 2022 | -1.02 | -0.96 | -5.96% | -54.55% | 1.15M | 4.924M | -76.65% | -82.44% |
| Q4 2021 | -0.36 | -0.86 | 57.99% | 41.94% | 55.6M | 6.321M | 779.61% | 727.38% |
| Q3 2021 | -0.95 | -0.79 | -20.57% | -1,800.00% | 5.44M | 6.465M | -15.85% | -86.95% |
| Q2 2021 | -0.86 | -0.67 | -27.75% | -26.47% | 2.84M | 5.559M | -48.91% | -20.89% |
| Q1 2021 | -0.66 | -0.60 | -10.85% | - | 6.55M | 6.715M | -2.46% | 71.02% |
| Q4 2020 | -0.62 | -0.31 | -101.77% | - | 6.72M | 8.729M | -23.02% | - |
| Q3 2020 | -0.05 | -0.34 | 85.48% | - | 41.69M | 4.097M | 917.57% | - |
| Q2 2020 | -0.68 | -0.58 | -17.25% | - | 3.59M | 4.154M | -13.58% | - |
| Q1 2020 | -0.66 | -0.51 | -29.85% | - | 3.83M | 5.106M | -24.99% | - |
Notes
CYTOKINETICS INC (CYTK) last reported earnings on 2/24/2026.
CYTOKINETICS INC (CYTK) missed EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, CYTOKINETICS INC (CYTK) has beaten EPS estimates in 2 out of 4 releases.